pT2K-CAGGSv3-murine IL-33-P2A-mCherry
(Plasmid
#256113)
-
PurposeTo examine IL-33 release during regulated cell death without tagging IL-33, while enabling mCherry-based selection via a P2A sequence.
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 256113 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backbonepT2K-CAGGSv3-EGFP
-
Backbone manufacturerK. Kawakami
- Backbone size w/o insert (bp) 8960
- Total vector size (bp) 8126
-
Vector typeMammalian Expression ; transposon-based vector
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameIL-33
-
Alt nameInterleukin-33
-
SpeciesM. musculus (mouse)
-
Insert Size (bp)867
-
MutationA P2A sequence is fused to the C-terminus of mIL-33, allowing ribosomal skipping and co-expression of mCherry as a separate protein.
-
GenBank IDNM_001360725.1
-
Entrez GeneIl33 (a.k.a. 9230117N10Rik, Il-33, Il1f11, NF-HEV)
- Promoter CAG
-
Tag
/ Fusion Protein
- P2A-mCherry (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site XbaI (destroyed during cloning)
- 3′ cloning site EcoRV (destroyed during cloning)
- 5′ sequencing primer cgccggcaggaaggaaat
- 3′ sequencing primer CCCTTGGTCACCTTCAGCTT
- (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pT2K-CAGGSv3-murine IL-33-P2A-mCherry was a gift from Hiroyasu Nakano (Addgene plasmid # 256113 ; http://n2t.net/addgene:256113 ; RRID:Addgene_256113) -
For your References section:
Temporal control of Ninj1 activation determines cell-to-cell heterogeneity in IL-33 release. Kanokogi T, Komazawa-Sakon S, Murai S, Moriwaki K, Shirasaki Y, Yamagishi M, Sumiyama K, Kishi K, Nakano H. Commun Biol. 2026 May 21. doi: 10.1038/s42003-026-10300-1. 10.1038/s42003-026-10300-1 PubMed 42168568